Yu-Chieh Tsai

Yu-Chieh Tsai

Auto-generated profile, based on publicly available information

Yu-Chieh Tsai

Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2007 in BJU International
Verified
Journal Article
Closed access
PDF file
CCChung-Hsin Chen
Chung-Hsin Chen
CSChia-Tung Shun
Chia-Tung Shun
KHKuo Huang
Kuo Huang
CHChao-Yuan Huang
Chao-Yuan Huang
YTYu‐Chieh Tsai
Yu‐Chieh Tsai
YPYeong-Shiau Pu
Yeong-Shiau Pu

7 July 2011 in The Prostate
Verified
Journal Article
Closed access
PDF file
SYShengqiang Yu
Shengqiang Yu
CYChiuan‐Ren Yeh
Chiuan‐Ren Yeh
YNYuanjie Niu
Yuanjie Niu
HCHong‐Chiang Chang
Hong‐Chiang Chang
YTYu‐Chieh Tsai
Yu‐Chieh Tsai
SYShuyuan Yeh
Shuyuan Yeh

1 November 2011 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
FHFeng-Ming Hsu
Feng-Ming Hsu
JLJang-Ming Lee
Jang-Ming Lee
PHPei-Ming Huang
Pei-Ming Huang
CLChia-Chi Lin
Chia-Chi Lin
CHChih-Hung Hsu
Chih-Hung Hsu
JCJason Chia-Hsien Cheng
Jason Chia-Hsien Cheng

16 March 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KHKuo Huang
Kuo Huang
KKKuan-Lin Kuo
Kuan-Lin Kuo
SCShyh-Chyan Chen
Shyh-Chyan Chen
TWTe-I Weng
Te-I Weng
YCYuan-Ting Chuang
Yuan-Ting Chuang
SLShing-Hwa Liu
Shing-Hwa Liu
Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that has been reported to elicit anti-proliferative response in various tumors. In this study, we aim to investigate the antitumor effect of celecoxib on urothelial carcinoma (UC) cells and the role endoplasmic reticulum (ER) stress plays in celecoxib-induced cytotoxicity. The cytotoxic effects were measured by MTT assay and flow cytometry. The cell cycle progression and ER stress-associated molecules were examined by Western blot and flow cytometry. Moreover, the cytotoxic effects of celecoxib combined with glucose-regulated protein (GRP) 78 knockdown (siRNA), (−)-epigallocatechin gallate (EGCG) or MG132 were assessed. We demonstrated that celecoxib markedly reduces the cell viability and causes apoptosis in human UC cells through cell cycle G1 arrest. Celecoxib possessed the ability to activate ER stress-related chaperones (IRE-1α and GRP78), caspase-4, and CCAAT/enhancer binding protein homologous protein (CHOP), which were involved in UC cell apoptosis. Down-regulation of GRP78 by siRNA, co-treatment with EGCG (a GRP78 inhibitor) or with MG132 (a proteasome inhibitor) could enhance celecoxib-induced apoptosis. We concluded that celecoxib induces cell cycle G1 arrest, ER stress, and eventually apoptosis in human UC cells. The down-regulation of ER chaperone GRP78 by siRNA, EGCG, or proteosome inhibitor potentiated the cytotoxicity of celecoxib in UC cells. These findings provide a new treatment strategy against UC.

24 December 2023 in European Journal of Cancer
Verified
Journal Article
Open access
YCYun Chiang
Yun Chiang
LLLi-Feng Lu
Li-Feng Lu
CTChao-Ling Tsai
Chao-Ling Tsai
YTYu-Chieh Tsai
Yu-Chieh Tsai
CWChung-Chieh Wang
Chung-Chieh Wang
JCJason Chia-Hsien Cheng
Jason Chia-Hsien Cheng
Our previous study revealed that elevated C-C motif chemokine ligand 2 (CCL2) secretion by irradiated cancer cells recruited C-C motif chemokine receptor 2 (CCR2)-positive myeloid cells and polarized M2-type tumor-associated macrophages (TAMs), promoting lung metastasis in an established mouse model. This study investigated the impact of CCL2 and TAMs on adaptive immunity. We assessed the influence of CCL2 and TAMs on adaptive immunity through two ectopic allograft mouse models constructed with MB49 bladder cancer cells and Lewis lung carcinoma cells. Both models exhibited delayed primary tumor growth following radiation therapy (RT), but RT promoted the development of pulmonary metastases in C57BL/6 mice. Additionally, we employed a direct coculture system to investigate the interaction between macrophages and target cells in the context of adaptive immunity. C-C motif chemokine receptor 4 (CCR4)-positive regulatory T cells (Tregs) were recruited to the postirradiated tumor microenvironment (TME). Utilizing a CCR4 antagonist to inhibit CCL2-CCR4 activation reversed the infiltration of CCR4 + Tregs and reduced the incidence of pulmonary metastases. In addition, a positive feedback loop between M2-type TAMs and Tregs was observed. The combined blockade of the CCL2-CCR4 and CCL2-CCR2 signaling pathways further decreased the risk of RT-promoted lung metastasis. The recruitment of CCR4 + Tregs to the postirradiated TME increases the metastatic potential of tumor cells through increased interactions with M2-type TAMs. A significant reduction in post-RT lung metastases in ectopic mouse models was achieved by disrupting the recruitment of both CCR4 + Tregs and CCR2 + myeloid cells, which are TAM precursors.